DrugPipeline.net has announced the addition of “Global Epilepsy Drugs Market 2016-2020” research report to their website DrugPipeline.net

Bangalore, India-- (SBWire) -- 07/13/2016 --Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology.

Etiology

Etiology varies according to the age of a person. Some individuals genetically inherit the disease while the cause of the disease in others is unknown. Head injuries, tumors, autism spectrum disorder, or stroke can also cause the disorder.

Report forecast the global epilepsy drugs market to grow at a CAGR of 4.45% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global epilepsy drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat and prevent epilepsy and related seizures. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of marketed drugs during the forecast period.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Epilepsy Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Eisai
- GSK
- Pfizer
- UCB

Other prominent vendors
- AbbVie
- Acorda Therapeutics
- Alexza Pharmaceuticals
- Aprecia Pharmaceuticals
- Aurobindo Pharma
- Biscayne Pharmaceuticals
- CURx Pharmaceuticals
- Dainippon Sumitomo Pharma
- D-Pharm
- F. Hoffmann-La Roche
- Grupo Ferrer Internacional
- GW Pharmaceuticals
- Insero Health
- INSYS Therapeutics
- Janssen Pharmaceuticals
- Ligand Pharmaceuticals
- H. Lundbeck
- MarcoPolo Pharmaceuticals
- Marinus Pharmaceuticals
- Meda
- Neurelis
- Nobelpharma
- Novartis
- Orphelia Pharma
- SAGE Therapeutics
- SciFlour
- Sedor Pharmaceuticals
- Shire
- SK Biopharmaceuticals
- Sun Pharmaceutical
- Sunovion Pharmaceuticals (US)
- Supernus Pharmaceuticals
- Takeda
- Turing Pharmaceuticals
- Upsher-Smith
- Valeant Pharmaceutical
- Zogenix

Market driver
- Tentative approval of late-stage pipeline molecules
- For a full, detailed list, view our report

Market challenge
- Social stigma associated with epilepsy
- For a full, detailed list, view our report

Market trend
- Reformulation of marketed drugs
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 87 pages "Global Epilepsy Drugs Market 2016-2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Pipeline analysis, Key buying criteria for anti-epileptic drugs, Market landscap, Market segmentation by generation of drugs, Market segmentation by spectrum of activity, Market segmentation by type of seizures, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-epilepsy-drugs-market-2016-2020

Related Report:

Global Endometriosis Drugs Market 2016-2020; visit - http://www.drugpipeline.net/technavio/global-endometriosis-drugs-market-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.